Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5792-5799

  Natsuga, Ken ^a   Nishie, Wataru ^a   Shinkuma, Satoru ^a   Ujiie, Hideyuki ^a   Nishimura, Machiko ^a   Sawamura, Daisuke ^b   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 17; COMPLEMENT; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN; NONCOLLAGENOUS 16A PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BULLOUS PEMPHIGOID; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; KERATINOCYTE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SKIN FRAGILITY;

ANIMALS; ANIMALS, NEWBORN; AUTOANTIBODIES; AUTOANTIGENS; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; EPITOPES; HUMANS; IMMUNIZATION, PASSIVE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; RABBITS;

EID: 84862097792     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003402     Document Type: Article

References (46)

1. Ishiko, A., H. Shimizu, A. Kikuchi, T. Ebihara, T. Hashimoto, and T. Nishikawa. 1993. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J. Clin. Invest. 91: 1608-1615. (Pubitemid 23127364)
2. Nonaka, S., A. Ishiko, T. Masunaga, M. Akiyama, K. Owaribe, H. Shimizu, and T. Nishikawa. 2000. The extracellular domain of BPAG2 has a loop structure in the carboxy terminal flexible tail in vivo. J. Invest. Dermatol. 115: 889-892.
3. Franzke, C. W., P. Bruckner, and L. Bruckner-Tuderman. 2005. Collagenous transmembrane proteins: recent insights into biology and pathology. J. Biol. Chem. 280: 4005-4008. (Pubitemid 40288560)
4. Shinkuma, S., J. R. McMillan, and H. Shimizu. 2011. Ultrastructure and molecular pathogenesis of epidermolysis bullosa. Clin. Dermatol. 29: 412-419.
5. Li, K., K. Tamai, E. M. Tan, and J. Uitto. 1993. Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5′-end of the gene and the 3′-untranslated region of the mRNA. J. Biol. Chem. 268: 8825-8834. (Pubitemid 23118673)
6. Shimizu, H., Y. Takizawa, L. Pulkkinen, J. J. Zone, K. Matsumoto, T. Saida, J. Uitto, and T. Nishikawa. 1998. The 97 kDa linear IgA bullous dermatosis antigen is not expressed in a patient with generalized atrophic benign epidermolysis bullosa with a novel homozygous G258X mutation in COL17A1. J. Invest. Dermatol. 111: 887-892. (Pubitemid 28509334)
7. Nakamura, H., D. Sawamura, M. Goto, H. Nakamura, M. Kida, T. Ariga, Y. Sakiyama, K. Tomizawa, H. Mitsui, K. Tamaki, and H. Shimizu. 2006. Analysis of the COL17A1 in non-Herlitz junctional epidermolysis bullosa and amelogenesis imperfecta. Int. J. Mol. Med. 18: 333-337.
8. McGrath, J. A., B. Gatalica, A. M. Christiano, K. Li, K. Owaribe, J. R. McMillan, R. A. Eady, and J. Uitto. 1995. Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat. Genet. 11: 83-86.
9. Asaka, T., M. Akiyama, T. Domon, W. Nishie, K. Natsuga, Y. Fujita, R. Abe, Y. Kitagawa, and H. Shimizu. 2009. Type XVII collagen is a key player in tooth enamel formation. Am. J. Pathol. 174: 91-100.
10. Mihai, S., and C. Sitaru. 2007. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J. Cell. Mol. Med. 11: 462-481. (Pubitemid 47160231)
11. Giudice, G. J., D. J. Emery, B. D. Zelickson, G. J. Anhalt, Z. Liu, and L. A. Diaz. 1993. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J. Immunol. 151: 5742-5750. (Pubitemid 23332383)
12. Anhalt, G. J., and L. A. Diaz. 1987. Animal models for bullous pemphigoid. Clin. Dermatol. 5: 117-125.
13. Liu, Z., L. A. Diaz, J. L. Troy, A. F. Taylor, D. J. Emery, J. A. Fairley, and G. J. Giudice. 1993. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemi-desmosomal antigen, BP180. J. Clin. Invest. 92: 2480-2488. (Pubitemid 23333558)
14. Nishie, W., D. Sawamura, M. Goto, K. Ito, A. Shibaki, J. R. McMillan, K. Sakai, H. Nakamura, E. Olasz, K. B. Yancey, et al. 2007. Humanization of autoantigen. Nat. Med. 13: 378-383. (Pubitemid 46376680)
15. Liu, Z., W. Sui, M. Zhao, Z. Li, N. Li, R. Thresher, G. J. Giudice, J. A. Fairley, C. Sitaru, D. Zillikens, et al. 2008. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J. Autoimmun. 31: 331-338.
16. Di Zenzo, G., S. Thoma-Uszynski, L. Fontao, V. Calabresi, S. C. Hofmann, T. Hellmark, N. Sebbag, C. Pedicelli, F. Sera, J. P. Lacour, et al. 2008. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin. Immunol. 128: 415-426.
17. Perriard, J., F. Jaunin, B. Favre, L. Büdinger, M. Hertl, J. H. Saurat, and L. Borradori. 1999. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J. Invest. Dermatol. 112: 141-147. (Pubitemid 29061967)
18. Hofmann, S., S. Thoma-Uszynski, T. Hunziker, P. Bernard, C. Koebnick, A. Stauber, G. Schuler, L. Borradori, and M. Hertl. 2002. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J. Invest. Dermatol. 119: 1065-1073. (Pubitemid 35430484)
19. Di Zenzo, G., F. Grosso, M. Terracina, F. Mariotti, O. De Pità, K. Owaribe, A. Mastrogiacomo, F. Sera, L. Borradori, and G. Zambruno. 2004. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J. Invest. Dermatol. 122: 103-110. (Pubitemid 38114646)
20. Chan, L. S., C. J. Vanderlugt, T. Hashimoto, T. Nishikawa, J. J. Zone, M. M. Black, F. Wojnarowska, S. R. Stevens, M. Chen, J. A. Fairley, et al. 1998. Epitope spreading: lessons from autoimmune skin diseases. J. Invest. Dermatol. 110: 103-109. (Pubitemid 28105841)
21. Di Zenzo, G., V. Calabresi, E. B. Olasz, G. Zambruno, and K. B. Yancey. 2010. Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model. J. Invest. Dermatol. 130: 1040-1047.
22. Di Zenzo, G., S. Thoma-Uszynski, V. Calabresi, L. Fontao, S. C. Hofmann, J. P. Lacour, F. Sera, L. Bruckner-Tuderman, G. Zambruno, L. Borradori, and M. Hertl. 2011. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J. Invest. Dermatol. 131: 2271-2280.
23. Iwata, H., N. Kamio, Y. Aoyama, Y. Yamamoto, Y. Hirako, K. Owaribe, and Y. Kitajima. 2009. IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment. J. Invest. Dermatol. 129: 919-926.
24. Messingham, K. N., R. Srikantha, A. M. DeGueme, and J. A. Fairley. 2011. FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid. J. Immunol. 187: 553-560.
25. Dmochowski, M., T. Hashimoto, B. S. Bhogal, M. M. Black, J. J. Zone, and T. Nishikawa. 1993. Immunoblotting studies of linear IgA disease. J. Dermatol. Sci. 6: 194-200. (Pubitemid 24024408)
26. Fritsch, A., S. Loeckermann, J. S. Kern, A. Braun, M. R. Bösl, T. A. Bley, H. Schumann, D. von Elverfeldt, D. Paul, M. Erlacher, et al. 2008. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J. Clin. Invest. 118: 1669-1679. (Pubitemid 351632371)
27. Fujita, Y., R. Abe, D. Inokuma, M. Sasaki, D. Hoshina, K. Natsuga, W. Nishie, J. R. McMillan, H. Nakamura, T. Shimizu, et al. 2010. Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice. Proc. Natl. Acad. Sci. USA 107: 14345-14350.
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
29. Natsuga, K., W. Nishie, S. Shinkuma, R. Moriuchi, M. Shibata, M. Nishimura, T. Hashimoto, and H. Shimizu. 2010. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid. Br. J. Dermatol. 162: 513-517.
30. Nishie, W., D. Sawamura, K. Natsuga, S. Shinkuma, M. Goto, A. Shibaki, H. Ujiie, E. Olasz, K. B. Yancey, and H. Shimizu. 2009. A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies. J. Immunol. 183: 4088-4093.
31. Ujiie, H., A. Shibaki, W. Nishie, D. Sawamura, G. Wang, Y. Tateishi, Q. Li, R. Moriuchi, H. Qiao, H. Nakamura, et al. 2010. A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen. J. Immunol. 184: 2166-2174.
32. Ujiie, H., A. Shibaki, W. Nishie, and H. Shimizu. 2010. What's new in bullous pemphigoid. J. Dermatol. 37: 194-204.
33. Ujiie, H., W. Nishie, and H. Shimizu. 2011. Pathogenesis of bullous pemphigoid. Dermatol. Clin. 29: 439-446, ix.
34. Liu, Z., G. J. Giudice, S. J. Swartz, J. A. Fairley, G. O. Till, J. L. Troy, and L. A. Diaz. 1995. The role of complement in experimental bullous pemphigoid. J. Clin. Invest. 95: 1539-1544.
35. Liu, Z., G. J. Giudice, X. Zhou, S. J. Swartz, J. L. Troy, J. A. Fairley, G. O. Till, and L. A. Diaz. 1997. A major role for neutrophils in experimental bullous pemphigoid. J. Clin. Invest. 100: 1256-1263. (Pubitemid 27386312)
36. Liu, Z., S. D. Shapiro, X. Zhou, S. S. Twining, R. M. Senior, G. J. Giudice, J. A. Fairley, and L. A. Diaz. 2000. A critical role for neutrophil elastase in experimental bullous pemphigoid. J. Clin. Invest. 105: 113-123. (Pubitemid 30036393)
37. Chen, R., G. Ning, M. L. Zhao, M. G. Fleming, L. A. Diaz, Z. Werb, and Z. Liu. 2001. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J. Clin. Invest. 108: 1151-1158. (Pubitemid 32995373)
38. Liu, Z., N. Li, L. A. Diaz, M. Shipley, R. M. Senior, and Z. Werb. 2005. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest. 115: 879-887. (Pubitemid 40489392)
39. Nelson, K. C., M. Zhao, P. R. Schroeder, N. Li, R. A. Wetsel, L. A. Diaz, and Z. Liu. 2006. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J. Clin. Invest. 116: 2892-2900. (Pubitemid 44684474)
40. Leighty, L., N. Li, L. A. Diaz, and Z. Liu. 2007. Experimental models for the auto-immune and inflammatory blistering disease, bullous pemphigoid. Arch. Dermatol. Res. 299: 417-422. (Pubitemid 47546926)
41. Wang, G., H. Ujiie, A. Shibaki, W. Nishie, Y. Tateishi, K. Kikuchi, Q. Li, J. R. McMillan, H. Morioka, D. Sawamura, et al. 2010. Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen. Am. J. Pathol. 176: 914-925.
42. Li, Q., H. Ujiie, A. Shibaki, G. Wang, R. Moriuchi, H. J. Qiao, H. Morioka, S. Shinkuma, K. Natsuga, H. A. Long, et al. 2010. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model. J. Immunol. 185: 7746-7755.
43. Sitaru, C. 2009. Bullous pemphigoid: a prototypical antibody-mediated organ-specific autoimmune disease. J. Invest. Dermatol. 129: 822-824.
44. Nishie, W., S. Lamer, A. Schlosser, E. Licarete, C. W. Franzke, S. C. Hofmann, J. Jackow, C. Sitaru, and L. Bruckner-Tuderman. 2010. Ectodomain shedding generates Neoepitopes on collagen XVII, the major autoantigen for bullous pemphigoid. J. Immunol. 185: 4938-4947.
45. Zillikens, D., P. A. Rose, S. D. Balding, Z. Liu, M. Olague-Marchan, L. A. Diaz, and G. J. Giudice. 1997. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J. Invest. Dermatol. 109: 573-579. (Pubitemid 27433604)
46. Fairley, J. A., C. L. Fu, and G. J. Giudice. 2005. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid. J. Invest. Dermatol. 125: 467-472.